Healthcare

WalletHub ranked states based on metrics like average annual salary and nurses per 1,000 residents.

Love Health will offer tongue cleaners, productivity gummies and herbal pills for menopause symptoms.

Doctors, policymakers and families agree: autistic Americans should have universal access to ABA therapy.

WINFertility reported a 150% increase in fertility preservation treatments over the last few years.

Health equity leaders share how employers and communities can prepare for further restrictions to care.

Rachel Jones, director of clinical implementation at WINFertility, shares how workplaces can support older moms.

Employers need to ensure their benefits are aligned with their efforts to support diversity and inclusion.

Georgia Robinette, lead counsel for Stephens Insurance, explains how employers can prepare for upcoming deadlines to their health plans.

The new partnership will extend discounted fertility care to 130,000 employees and their families.

Dr. Eric Bricker, medical director of SimplePay Health, reveals how employers can eliminate barriers to care.

Tom Kelly, benefits specialist at Buck, explains why employers should offer long-term insurance to their workforce.

The filing comes after a federal appeals court partially stayed a ruling that would suspend mifepristone's approval by the FDA.

Nava Benefits launched an app that helps hold the brokerage accountable for plans they sold to employers.

The insurance giant's pharmacy-benefit management unit will market a "fully transparent" option charging a flat monthly fee for each member.

Ninety percent of Gen Z say they've experienced symptoms of anxiety or depression due to stress.

Dr. Daniel Selling explains what it takes to successfully connect with the right mental health provider.

A plan of attack for finding and destroying targets can be used to eliminate pain points associated with healthcare claims.

In a joint open letter, executives said the ruling undermined the U.S. regulators authority.

Policy advocates, doctors and families agree: abortion care access and benefits can save lives.

Texas federal court judge Matthew Kacsmaryk will order the FDA to withdraw its approval for the abortion pill mifepristone.